Open Access
Subscription Access
Bronchial Asthma and the Role of Medications
Abstract
The leukotrienes modifiers such as montelukast stop the action of leukotrienes inflammatory substances that ply a role primarily vasthma. Mast cell stabilizers such as cromolyn stop the release of histamine and other inflammatory substances from mast cells. Anti cholinergic agents namely ipratropium bromide used in combination with SABs and this drug helps in relaxing the airways by blocking acetylcholine, a neurotransmitter that can constric them. It is more frequently used in chronic obstructive pulmonary disease ( COPD). Omlizumab is mono clonal antibody targets immuno globulin E ( Ig E) and decreases the immune response that activates asthma symptoms. It is meant for severe allergic asthma cases.
Finally it is concluded that bronchial asthma plays a multifaceted approach along with medications
References
Lee J, McDonald C. Review: Immunotherapy improves some symptoms and reduces long-term medication use in mild to moderate asthma. Ann Intern Med. 2018 Aug 21;169(4):JC17. [PubMed]
Tesfaye ZT, Gebreselase NT, Horsa BA. Appropriateness of chronic asthma management and medication adherence in patients visiting ambulatory clinic of Gondar University Hospital: a cross-sectional study. World Allergy Organ J. 2018;11(1):18. [PMC free article] [PubMed]
Salo PM, Cohn RD, Zeldin DC. Bedroom Allergen Exposure Beyond House Dust Mites. Curr Allergy Asthma Rep. 2018 Aug 20;18(10):52. [PMC free article] [PubMed]
Scirica CV, Celedón JC. Genetics of asthma: potential implications for reducing asthma disparities. Chest. 2007 Nov;132(5 Suppl):770S-781S. [PubMed]
Piloni D, Tirelli C, Domenica RD, Conio V, Grosso A, Ronzoni V, Antonacci F, Totaro P, Corsico AG. Asthma-like symptoms: is it always a pulmonary issue? Multidiscip Respir Med. 2018;13:21. [PMC free article] [PubMed]
Aggarwal B, Mulgirigama A, Berend N. Exercise-induced bronchoconstriction: prevalence, pathophysiology, patient impact, diagnosis and management. NPJ Prim Care Respir Med. 2018 Aug 14;28(1):31. [PMC free article] [PubMed]
Yii AC, Soh AZ, Chee CBE, Wang YT, Yuan JM, Koh WP. Asthma, Sinonasal Disease, and the Risk of Active Tuberculosis. J Allergy Clin Immunol Pract. 2019 Feb;7(2):641-648.e1. [PMC free article] [PubMed]
D'Amato M, Molino A, Calabrese G, Cecchi L, Annesi-Maesano I, D’Amato G. The impact of cold on the respiratory tract and its consequences to respiratory health. Clin Transl Allergy. 2018;8:20. [PMC free article] [PubMed]
Burrows B, Barbee RA, Cline MG, Knudson RJ, Lebowitz MD. Characteristics of asthma among elderly adults in a sample of the general population. Chest. 1991 Oct;100(4):935-42. [PubMed]
Martin AJ, Landau LI, Phelan PD. Lung function in young adults who had asthma in childhood. Am Rev Respir Dis. 1980 Oct;122(4):609-16. [PubMed]
Southworth T, Kaur M, Hodgson L, Facchinetti F, Villetti G, Civelli M, Singh D. Anti-inflammatory effects of the phosphodiesterase type 4 inhibitor CHF6001 on bronchoalveolar lavage lymphocytes from asthma patients. Cytokine. 2019 Jan;113:68-73. [PubMed]
Gosens R, Gross N. The mode of action of anticholinergics in asthma. Eur Respir J. 2018 Oct;52(4) [PMC free article] [PubMed]
Almadhoun K, Sharma S. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Apr 28, 2023. Bronchodilators. [PubMed]
Jilani TN, Preuss CV, Sharma S. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): May 1, 2023. Theophylline. [PubMed]
Rajan S, Gogtay NJ, Konwar M, Thatte UM. The global initiative for asthma guidelines (2019): change in the recommendation for the management of mild asthma based on the SYGMA-2 trial – A critical appraisal. Lung India. 2020 Mar-Apr;37(2):169-173. [PMC free article] [PubMed]
Sly RM. Changing asthma mortality. Ann Allergy. 1994 Sep;73(3):259-68. [PubMed]
Melgarejo González-Conde V, Pérez-Fernández V, Ruiz-Esteban C, Valverde-Molina J. Impact of Self-Efficacy on The Quality of Life of Children With Asthma and Their Caregivers. Arch Bronconeumol (Engl Ed). 2019 Apr;55(4):189-194. [PubMed]
Banasiak NC. Implementation of the Asthma Control Test in Primary Care to Improve Patient Outcomes. J Pediatr Health Care. 2018 Nov-Dec;32(6):591-599. [PubMed]
Konstantakopoulou O, Kaitelidou D, Economou C, Charalambous G. Barriers in Access to Pharmaceutical Care in Greece: The Case Study of the Out-of-Hospital Management of Patients With Acute Asthma. Front Public Health. 2018;6:199. [PMC free article] [PubMed]
Piñera Salmerón P, Delgado Romero J, Domínguez Ortega J, Labrador Horrillo M, Álvarez Gutiérrez FJ, Martínez Moragón E, Plaza Moral V, Álvarez Rodríguez C, Miguel Franco J. Management of asthma in the emergency department: a consensus statement. 2018 AgoEmergencias. 30(4):268-277. [PubMed]
Chen S, Golam S, Myers J, Bly C, Smolen H, Xu X. Systematic literature review of the clinical, humanistic, and economic burden associated with asthma uncontrolled by GINA Steps 4 or 5 treatment. Curr Med Res Opin. 2018 Dec;34(12):2075-2088. [PubMed]
Bernstein JA, Mansfield L. Step-up and step-down treatments for optimal asthma control in children and adolescents. J Asthma. 2019 Jul;56(7):758-770. [PubMed]
Refbacks
- There are currently no refbacks.